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To investigate the involvement of different types of glutamate receptors in recognition memory, selective antagonists of NMDA and
kainate receptors were locally infused into the perirhinal cortex of the rat temporal lobe. Such infusion of a selective kainate receptor
antagonist produced an unusual pattern of recognition memory impairment: amnesia after a short (20 min) but not a long (24 h) delay.
In contrast, antagonism of perirhinal NMDA glutamate receptors by locally infused AP-5 (2-amino-5-phosphonopentanoic acid) im-
paired recognition memory after the long but not the short delay. For both drugs, impairment was found when the drug was present
during acquisition but not when it was present during retrieval. Experiments in vitro indicate that selective antagonism of NMDA
receptors containingNR2Asubunitsblocksperirhinal long-termpotentiation (LTP),whereas antagonismofNMDAreceptors containing
NR2B subunits blocks long-term depression (LTD). However, recognition memory after a 24 h delay was impaired only when both an
NR2A and an NR2B antagonist were infused together, not when either was infused separately. These results establish that kainate
receptors have a role in recognition memory that is distinct from that of NMDA receptors, that there must be at least two independent
underlying memory mechanisms in the infused region, that this region and no other is necessary for both short-term and long-term
familiarity discrimination, and that perirhinal-dependent long-term recognition memory does not rely solely on processes used in
NMDA-dependent LTP or LTD (although it might be independently supported by components of each type of process with one substi-
tuting for the other).
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Introduction
The central role of the perirhinal cortex in recognition memory,
particularly familiarity discrimination for individual objects, has
been established through both ablation and recording studies in
monkeys and rats (Brown et al., 1987; Gaffan and Murray, 1992;
Fahy et al., 1993; Li et al., 1993; Meunier et al., 1993; Miller et al.,
1993; Suzuki et al., 1993; Ennaceur et al., 1996; Ringo, 1996;
Suzuki, 1996; Xiang and Brown, 1998; Murray and Bussey, 1999;
Brown and Aggleton, 2001). This localization of function makes
possible the investigation of the role of specific types of glutamate
receptors in this type of memory. In particular, localized bilateral
infusion of a muscarinic receptor antagonist into the rat perirhi-
nal cortex has recently been shown to produce an impairment of
recognitionmemory (Warburton et al., 2003), in agreement with
findings in the monkey (Tang et al., 1997). This technique estab-
lishes that receptor-dependent processes within the perirhinal
cortex can be targeted selectively. Notably, it also allows investi-
gation of whether particular glutamate receptor-dependent plas-
tic processes found in the perirhinal cortex may be required for
recognition memory. Previous work on the hippocampus using
the selective NMDA glutamate receptor antagonist 2-amino-5-
phosphonopentanoic acid (AP-5) has implicated NMDA recep-
tors in both memory and synaptic plasticity (Collingridge et al.,
1983; Morris et al., 1986; Bliss and Collingridge, 1993; Banner-
man et al., 1995). Research on the perirhinal cortex has demon-
strated that antagonism of its NMDA receptors in vitro blocks the
induction of both long-term potentiation (LTP) and long-term
depression (LTD) and in vivo impairs recognition memory (Zia-
kopoulos et al., 1999; Cho et al., 2000;Winters and Bussey, 2005).
Recently, the use of more selective antagonists has indicated that
perirhinal plasticity demonstrates a particular dependency on
subtypes of NMDA receptors (Massey et al., 2004). Thus, selec-
tive antagonism of NMDA receptors containing an NR2A sub-
unit blocks the induction of LTP (and depotentiation) but not
LTD, whereas selective antagonism of NMDA receptors contain-
ing an NR2B subunit blocks LTD but not LTP (or depotentia-
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tion). Accordingly, the use of such subunit-selective antagonism
provides a means to investigate whether processes involved in
LTP or LTD underlie perirhinal-based recognition memory.
Such investigations therefore allow a test of the Bogacz and
Brown (2003) computational model of familiarity discrimina-
tion, which predicts that the primary synaptic change should be a
synaptic weakening such as occurs in LTD.
In contrast toNMDA receptors, the potential cognitive role of
kainate glutamate receptors has previously remained unclear be-
cause of a lack of selective antagonists or conditional, regionally
specific transgenic animals. The availability of a new selective
kainate receptor antagonist (of GluK5 subunit-containing recep-
tors) now allows test of the role of these receptors to be made
(More et al., 2004) and therefore for this role to be comparedwith
that of NMDA receptors. Accordingly, by using the localized de-
livery of selective antagonists, here we report the contrasting ef-
fects on recognition memory of selective antagonism of NMDA
or kainate glutamate receptors in the rat perirhinal cortex and
discuss the implications of the findings for the types of plastic
processes that may underlie perirhinal-dependent recognition
memory.
Materials andMethods
Subjects.Male pigmented rats (Dark Agouti strain; Bantin and Kingman,
Hull, UK), weighing 150–200 g at the start of the experiment, were
housed under a 12 h light/dark cycle. Behavioral training and testingwere
conducted during the dark phase of the cycle (6:00A.M. to 6:00 P.M.). All
procedures accorded to the United Kingdom Animals Scientific Proce-
dures Act (1986) and associated guidelines and had approval of the Uni-
versity of Bristol Ethical Review Committee.
Cannulation surgery. Each of 30 rats was anesthetized with isoflurane
and secured in a stereotaxic frame with the incisor bar set at 3.3 mm
below the interaural line. Two stainless steel guide cannulas (26 gauge;
Plastics One, Semat, UK) were implanted through burr holes in the skull
at an angle of 20° to the vertical, using the following coordinates: antero-
posterior,5.6mm from bregma; lateral,4.47mm; vertical,6.7mm
from skull surface. The cannulas were anchored to the skull by two stain-
less steel screws and dental cement. Between infusions, the cannulas were
closed by dummy inserts. After surgery,14 dwere allowed for recovery.
Apparatus. Exploration occurred in an open-topped arena (90 100
cm) with 50 cm wood walls and a scaffold covered with black cloth to a
height of 150 cm, so that no external stimuli could be seen during the
experiment. The floor was covered with sawdust. An overhead camera
and video recorder were used to monitor and record the animal’s behav-
ior for subsequent analysis. The stimuli were triplicate copies of objects
made of plastic that varied in shape, color, and size (10 10 5 cm to
25 10 5 cm) and were too heavy for the animal to displace.
Training. After 1 week of handling, each animal was habituated to the
arena without stimuli for 10min daily for 4 d before the commencement
of the spontaneous recognition procedure. This procedure comprised an
acquisition phase separated by a delay from a recognition test. In the
acquisition phase, duplicate copies of an object (e.g., A1 and A2) were
placed near the two corners at either end of one side of the arena (10 cm
from each adjacent wall). The animal was placed into the arena facing the
center of the opposite wall and allowed a total of either 40 s of exploration
of A1 and A2 or 4 min in the arena. Exploratory behavior was defined as
the animal directing its nose toward the object at a distance of 2 cm.
Other behaviors such as looking around while sitting on or resting
against the object were not considered as exploration. The delay between
the phases was 20 min or 24 h. At test (3 min duration), the animal was
replaced in the arena and presented with two objects using the same
positions as at acquisition: one object (A3) was the third copy of the
object used in the sample phase, and the other was a novel object (B3).
The positions of the objects in the test and the objects used as novel or
familiar were counterbalanced between the animals in a group and be-
tween the control and drug-treated groups.
Drug delivery. General procedures followed Warburton et al. (2003).
The drugs used were AP-5 (Tocris Cookson, Ellisville, MO), (S)-1-(2-
amino-2-carboxyethyl)-3-(2-carboxybenzyl)pyrimidine-2,4-dione
(UBP302) (supplied by D.E.J.), (R-(R*,S*)--(4-hydroxyphenyl)--
methyl-4-(phenylmethyl)-1-piperidine propanol (Ro 25-6981) (Sigma-
Aldrich, Poole, UK), and (1RS,1S)-[[1-(4-bromo-phenyl)-ethyl-
amino]-(2,3-dioxo-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methyl]-
phosphonic acid (NVP AAM077) (supplied by Dr. Y. Auberson,
Novartis Pharma, Basel, Switzerland). AP-5 was dissolved in sterile 0.9%
saline solution. Other drugs were dissolved initially in 0.1 M NaOH and
0.9% saline before further dilution with 0.9% saline. Control infusions
consisted of saline with a concentration of 0.1 MNaOH equivalent to that
of the drug solution. AP-5 was infused at a concentration of 25 mM,
UBP302 was infused at a concentration of 1.5 mM, Ro 25-6981 was in-
fused at a concentration of 30 M, and NVP AAM077 was infused at a
concentration of 10 M. Infusions were made into the perirhinal cortex
through a 33 gauge cannula (Plastics One) inserted into the implanted
cannula and attached to a 5l Hamilton syringe via polyethylene tubing.
A volume of 1.0l was injected into each hemisphere over a 2min period
by infusion pump (Harvard Bioscience, Holliston, MA). The infusion
cannula remained in place for an additional 5 min.
Design. A different group of rats was used to test the effects of each of
the compounds, with two groups being used for AP-5 (one for the acqui-
sition and one for the consolidation and retrieval experiments). The
animals were tested after a 20 min or 24 h delay. Where both delays were
tested for a given drug, the same animals were used with a 7 d rest
between experiments. Two designs were used. (1) To examine whether
NMDA or kainate receptors were involved in the acquisition stage of
memory, the appropriate antagonist or vehicle was infused starting 15
min before the commencement of the acquisition phase. After 7 d, the
other substance (vehicle or antagonist in a crossover design) was infused,
and the animal was tested again. (2) To study whether NMDA (or kai-
nate) receptors were involved in retrieval or consolidation, the injection
was given 2 min after the acquisition phase. Again, testing after injection
of the other substance followed 7 d later. The group sizes (n) were as
follows: AP-5 experiments, n  7 for testing acquisition and n  8 for
testing retrieval or consolidation; UBP302 experiments, n  7; NVP
AAM077 and Ro 25-6981, n 8. Data were analyzed only from animals
that completed all phases of an experiment with patent, correctly placed
cannulas.
Statistical analysis. All measures of exploration were made with the
experimenter blind as to the treatment. The discrimination ratio (DR)
was calculated as the difference in time spent by each animal exploring
the novel compared with the familiar object divided by the total time
spent exploring both objects. Comparisons for the vehicle- and drug-
treated groups used an ANOVA with repeated measures with time as a
between-subjects factor and treatment (drug or vehicle) as a within-
subjects factor. One-sample t tests were used to determine the signifi-
cance of the DR (compared with zero discrimination) for each group. All
tests used a significance level of p 0.05 and were two-tailed.
Histology.At the end of the experiment, each rat was anesthetized with
Euthetal and perfused transcardially with PBS, followed by 4% parafor-
maldehyde. The brain was postfixed in paraformaldehyde for a mini-
mum of 2 h before being transferred to 30% sucrose in 0.2 M phosphate
buffer and left overnight. Coronal sections were cut at 50 m on a cryo-
stat and stained with cresyl violet. Cannula locations were checked
against standardized sections of the rat brain. Histological examination
confirmed that infusions were made into the perirhinal cortex (Shi and
Cassell, 1999) in all cases. From unpublished observations in the labora-
tory, using Indian ink andbiotinylated oligonucleotides for visualization,
the region infused is estimated to be 1–1.5 mm3, with the region being
primarily confined to the perirhinal cortex. This spread is consistent with
previously quoted results in other brain regions (Martin, 1991; Izquierdo
et al., 2000; Attwell et al., 2001).
Results
The selective kainate (GLUK5) receptor antagonist UBP302 (1.5
mM) was infused locally into a rat’s perirhinal cortex via bilater-
ally implanted cannulas (Warburton et al., 2003) (Fig. 1). Recog-
nitionmemory wasmeasured by the preferential exploration of a
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novel rather than a familiar object (Ennaceur and Delacour, 1988),
using delays of 20 min and 24 h. For each delay, UBP302 or vehicle
was infused15minbefore the initial familiarizationwithanobject to
investigate the effect of blocking kainate receptors during the famil-
iarization (acquisition). Analysis of exploration behavior at the sub-
sequent test indicated a significant interaction between treatment
(drug or vehicle) and delay (ANOVA: F(1,12)  7.5, p  0.02).
Further analysis revealed that for the UBP302 group, recognition
memory was impaired compared with vehicle controls after a
delay of 20 min (ANOVA: F(1,6) 20.5, p 0.005) but not when
the delay was 24 h (F(1,6) 1; p  0.1) (Fig. 2). Indeed, the per-
formance of the UBP302-treated group differed significantly at
the two timedelays (F(1,12) 5.19; p 0.05).Drug infusion 2min
after acquisition with the test at a 20 min delay did not impair
familiarity discrimination, so that UBP302 did not impair con-
solidation or retrieval mechanisms (Table 1). The drug was with-
out effect on exploration levels (Table 2).
AP-5 (25 mM) or vehicle was infused 15 min before the initial
familiarization with an object to investigate the effect of blocking
NMDA receptors during the familiarization (acquisition). Anal-
ysis of exploration behavior at subsequent tests at delays of 20
min or 24 h indicated a significant interaction between treatment
and delay (ANOVA: F(1,12) 6.4, p 0.03). In striking contrast
to the effect of UBP302, further analysis revealed that AP-5 im-
paired recognitionmemory compared with vehicle controls after
a delay of 24 h (ANOVA: F(1,6) 10.9, p 0.02) but not 20 min
(F(1,6) 1; p 0.1) (Fig. 2). The performance of theAP-5-treated
group at the two time delays differed sig-
nificantly (F(1,12)  14.7; p  0.005) (Fig.
3). The impairment with the combined
drug infusion could not be explained by
differences in exploration during the sam-
ple or test phases (see Table 2 for details).
To exclude the possibility that the dose
level was precisely that required to pro-
duce impairment only at the longer delay,
when memory might be expected to be
weaker, the experimentwas repeated using
an infusion of 40 mM AP-5. Again, there
was no impairment with a delay of 20min.
Additionally, impairment remained when
infusions were made before both acquisi-
tion and the test at 24 h, so that state-
dependent impairment could be excluded:
the performance of the vehicle control and
AP-5 groups differed significantly (ANOVA: F(1,8)  16.9, p 
0.01), with the control group showing significant (t(8) 3.4; p
0.01) discrimination of the novel over the familiar object,
whereas the AP-5 group did not (t(8)  0.7; p  0.1). In an
additional experiment, infusion (25mMAP-5) 2min after acqui-
sition did not impair familiarity discrimination at either 20 min
or 24 h delay, so that AP-5 did not impair consolidation mecha-
nisms; the result at 20 min also established that AP-5 did not
impair retrieval (Table 1).
The effects of antagonizing NMDA receptors containing ei-
ther NR2A or NR2B subunits were investigated by infusing the
NR2A-selective antagonist NVPAAM077 (Auberson et al., 2002)
or the NR2B-selective antagonist Ro 25-6981 (Fischer et al.,
1997). Three experiments were performed in which infusions
were made of NVP AAM077 (10 M) or Ro 25-6981 (30 M) or
both drugs together. Drug or vehicle infusions weremade 15min
before the initial familiarization with an object, so that either
NR2A- or/and NR2B-containing NMDA receptors were blocked
during familiarization. Analysis of exploration behavior at sub-
sequent test after a delay of 24 h indicated a significant interaction
between treatment and experiment (ANOVA: F(2,21) 7.33, p
0.005). In contrast to the effect of AP-5, neither NVP AAM077
nor Ro 25-6981 infused alone impaired preferential exploration
relative to vehicle controls at a delay of 24 h (ANOVAs: F(1,7) 
1.0, p  0.05) (Fig. 4). Memory after a delay of 20 min was not
tested because there was no impairment at this delay with AP-5.
However, when NVP AAM077 (10 M) and Ro 25-691 (30 M)
were infused together, recognition memory at a 24 h delay was
significantly impaired compared with controls (F(1,7) 16.6; p
0.005), as found for AP-5 (Fig. 4). The memory differences be-
tween the individual and the combined infusions were significant
(ANOVA, Bonferroni-corrected comparisons ofmeans) for both
NVP AAM077 ( p  0.005) and Ro 25-6981 ( p  0.03). The
impairment with the combined drug infusion could not be ex-
plained by differences in exploration during the sample or test
phases (Table 2).
Discussion
The results of local infusions into the perirhinal cortex establish
that recognition memory is impaired when kainate receptors are
selectively antagonized by UBP302 at a delay of 20 min but not
24 h and when NMDA receptors are selectively antagonized by
AP-5, or by NVP AAM077 and Ro 25-6981 given together, at a
delay of 24 h but not 20 min. The impairment produced by kai-
nate receptor antagonism is unusual because there is short-term
Figure1. Infusion sites. The siteswithin theperirhinal cortex atwhichAP-5,UBP302,NVPAAM077 (NVP), andRo25-6981 (Ro)
were infused are shown in the boxes expanded froma schematic brain section. Hpc, Hippocampus; RS, rhinal sulcus; Th, thalamus.
Figure 2. Perirhinal infusion of UBP302 impairs shorter-term (20 min) but not longer-term
(24 h) recognition memory. Illustrated for each group is the mean (SEM) DR (proportion of
additional time spent exploring a novel rather than a familiar object). At both 20min and 24 h,
the DRwas significantly different from zero (no discrimination between novel and familiar) for
rats infusedwith vehicle (DR 0: t(6) 4.3, p 0.01 and t(6) 2.9, p 0.05, respectively).
In contrast, for rats infusedwithUBP302, theDRwasnot significant fromzero at 20minbutwas
at 24 h (t(6) 0.5, p 0.1 and t(6) 3.1, p 0.05, respectively). *p 0.05 difference
between the 20 min and 24 h delay in the UBP302-treated group; **p  0.01, difference
between the vehicle- and UBP302-treated groups at the 20 min delay.
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amnesia, followed by long-term remembrance. The observed im-
pairments were in the acquisition of information because mem-
ory was not impaired when infusion of UBP302 or AP-5 was after
acquisition. The impairment at 24 h produced by AP-5 is in
agreement with other recently reported findings (Winters and
Bussey, 2005), except that an effect on consolidation as well as
acquisition was reported in that study. The studies differ in rat
strain, memory delay, and the precise doses used; however, the
lack of effect on consolidation in the present experiments is most
probably attributable to the slightly longer delay between the start
of the familiarization (acquisition) phase anddrug infusion in the
present study. Accordingly, memory acquisition underlying fa-
miliarity discrimination for individual objects is kainate receptor
independent at a delay of 24 h, although it is kainate receptor
dependent at a delay of 20 min. In contrast, such memory acqui-
sition is NMDA receptor dependent at a delay of 24 h, although it
is NMDA receptor independent at a delay of 20 min.
That the amnesia at the short delay is kainate receptor depen-
dent may be accepted with confidence because, at the dose used,
UBP302 has negligible agonist or antagonist activity at other
common neurotransmitter receptors, including other glutamate
and muscarinic cholinergic receptors (More et al., 2004). Thus,
UBP302 is the active S enantiomer of UBP296. The racemic
mixture (RS)-1-(2-amino-2-carboxyethyl)-3-(2-carboxybenzyl)
pyrimidine-2,4-dione (UBP296) is a selective GLUK5 receptor
antagonist (KB value 0.6M) with no activity on NMDA (50M)
or GLUK6 or GLUK2 receptors (100 M) (More et al., 2004).
UBP302 is a potent antagonist of native GLUK5 receptors on
spinal dorsal root (KD value 0.4 M) with 	260-fold selectivity
versus native AMPA receptors expressed
on spinal neurons (More et al., 2004). In
recent studies, UBP296 has been shown to
have no activity at 300Mon recombinant
homomeric human GLUA1–4 AMPA re-
ceptors and has no agonist or antagonist
activity at 100 M when tested on recom-
binant homomeric human M1–M5 mus-
carinic cholinergic receptors (A. J. Alt,
C. C. Felder, and D. E. Jane, unpublished
observations). Thus, one can be confident that UBP302 is GLUK5
selective and its effects occur via kainate receptors.
It is theoretically possible that any UBP302-induced impair-
ment at the long delay is masked by memory that is independent
of the infused region (e.g., by the formation of another memory
trace outside the infused region). However, the existence of such
an additional memory trace may be excluded, because when the
perirhinal region is infused with AP-5, there is memory impair-
ment at the long delay. Hence, operation of the infused region is
essential to recognition memory at the long delay, and no other
region can compensate. Indeed, all attempts to explain the results
through memory being set up in another region meet the diffi-
culty that the hypothesized additional region has to be necessary
for memory at 20 min but not 24 h when AP-5 is infused into the
perirhinal cortex and for memory at 24 h but not 20 min when
UBP302 is infused into the perirhinal cortex. Such a situation is
implausible. Hence, in particular, the hippocampus fails to pro-
vide an alternative memory site. The critical region is likely to be
the perirhinal cortex because the infusion is likely to have reached
most of the perirhinal cortex (Shi and Cassell, 1999) and, on the
basis of work in other areas (Martin, 1991; Izquierdo et al., 2000;
Attwell et al., 2001), is unlikely to have affected more than a
minor part of either of the adjacent regions of area Te2 or the
entorhinal cortex.
It follows that there is more than one recognition memory
mechanismoperatingwithin the perirhinal and adjacent cortices:
anNMDAreceptor-dependentmechanism that is responsible for
memory at 24 h and a kainate receptor-dependent mechanism
Table 1. Tests of consolidation and retrieval
Infusion 20 min delay 24 h delay
UBP302 DR 0.47  0.12 (t(6) 3.7; p 0.05)
Vehicle DR 0.38  0.07 (t(6) 5.8; p 0.001)
AP-5 DR 0.47  0.07 (t(7) 6.4; p 0.001) DR 0.36  0.05 (t(7) 6.9; p 0.001)
Vehicle DR 0.26  0.08 (t(7) 3.2; p 0.05) DR 0.50  0.05 (t(7) 9.6; p 0.001)
Vehicle or drug was infused 2min after the completion of the acquisition test. In each case for each delay tested, the DRwas significantly different from zero
(one-sample t test), indicating a lack of effect on consolidation or retrieval. There were no differences in exploration at acquisition or test (data not shown).
Table 2. Exploration times
Infusion Delay Time to complete acquisition phase (s) Total exploration in acquisition phase (s) Total exploration in test phase (s)
Vehicle 20 min (n 7) 240  0.3 28  2 18  2
UBP302 239  0.3 31  2 20  1
(F(1,6) 1.0; NS) (F(1,6) 1.0; NS) (F(1,6) 1.0; NS)
Vehicle 24 h (n 7) 240  0 27  2 22  2
UBP302 239  1 33  1 21  3
(F(1,6) 1.0; NS) (F(1,6) 4.54; NS) (F(1,6) 1.0; NS)
Vehicle 20 min (n 7) 238  2 30  2 23  3
AP-5 236  3 30  2 27  4
(F(1,6) 1.0; NS) (F(1,6) 1.0; NS) (F(1,6) 1.0; NS)
Vehicle 24 h (n 7) 229  8 32  3 27  1
AP-5 223  12 33  1 33  2
(F(1,6) 1.0; NS) (F(1,6) 1.0; NS) (F(1,6) 13.4; p 0.01)
Vehicle 24 h (n 8) 214  18 34  2 30  4
Ro 25-6981 239  1 31  2 26  3
(F(1,7) 1.9; NS) (F(1,7) 1.0; NS) (F(1,7) 1.0; NS)
Vehicle 24 h (n 8) 237  3 29  2 17  1
NVP AAM077 233  7 29  2 20  1
(F(1,7) 1.0; NS) (F(1,7) 1.0; NS) (F(1,7) 5.7; p 0.05)
Vehicle 24 h (n 8) 220  11 36  1 20  3
Ro 25-6981 plus NVP AAM077 200  18 35  3 26  2
(F(1,7) 1.1; NS) (F(1,7) 1.0; NS) (F(1,7) 2.5; NS)
When vehicle or drugwas infused before acquisition, no significant differencewas found in exploration times, indicating no significant (NS) effect of the drugs on general behavior, except for 2 of the 24 tests at the 24 h delaywhen the drugs
would not have still been active. There were no significant differences for any test during acquisition, including when drugs would have been active.
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that is responsible for memory at 20 min. The conclusion that
there must be more than one recognition memory mechanism
within the perirhinal and adjacent cortices is in accord with the
findings of neuronal recording experiments (Fahy et al., 1993;
Xiang and Brown, 1998). Indeed, the fast-onset plasticity of the
so-called recency and novelty responses compared with the slow-
onset, long-lasting plasticity of familiarity responses (Xiang and
Brown, 1998) provides a potential explanation of the behavioral
findings if the fast changes are kainate receptor dependent (sup-
porting memory at the shorter delay) and the slow changes are
NMDA receptor dependent (supporting memory at the longer
delay).
The present results have major implications for potential un-
derlying plasticity mechanisms. First, the underlying kainate-
dependent synaptic plastic mechanism is expressed relatively
rapidly (20 min) but is relatively short lasting because it is
insufficient to support memory at the 24 h delay. Second, the
NMDA receptor-dependent plastic process in the perirhinal cor-
tex is long-lasting (24 h), but the underlying synaptic change
must develop slowly, otherwise the NMDA-dependent process
should prevent there being amnesia at the short delay. Given this,
then a classical, rapidly induced NMDA receptor-dependent
LTP-like plastic process, as seen in the hippocampus (Col-
lingridge et al., 1983; Bliss and Collingridge, 1993) and perirhinal
cortex (Ziakopoulos et al., 1999; Cho et al., 2000), is not essential
to perirhinal familiarity discrimination. Such plasticity is marked
by rapid induction and expression and therefore should have
supported memory at 20 min even when kainate receptors were
antagonized, but the results demonstrate that memory was im-
paired at this delay so that a rapidly induced, NMDA-dependent,
LTP-like process cannot underlie such memory. This conclusion
is further supported by the finding that scopolamine impairs
recognitionmemory after a delay of 20min but does not block the
induction of perirhinal LTP (Warburton et al., 2003). In contrast,
scopolamine does block the induction of perirhinal LTD (Warbur-
ton et al., 2003); however, as discussed below, the findings of the
present experiments arenot readily consistentwitha singleLTD-like
process underlying familiarity discrimination. Thus, although the
results do not disprove the computational model of Bogacz and
Brown (2003), they do indicate that it is likely to represent an over-
simplification (but see Bogacz et al., 2001).
Further implications concerning potential underlying plastic-
ity mechanisms arise from the findings using subunit-specific
NMDA receptor antagonists. At a long delay (24 h), familiarity
discrimination was not impaired by antagonism of either NR2A
subunit-containing or NR2B subunit-containing NMDA recep-
tors on their own. The selectivity of the two antagonists used
(NVP AAM077 and Ro 25-6981) has been established in vitro
(Fischer et al., 1997; Auberson et al., 2002); in particular, within
slices of the adult rat perirhinal cortex, their effects on LTP (and
depotentiation) and LTD are unequivocally differentiable (Mas-
sey et al., 2004). Similarly, the behavioral effects after recognition
memory were clear cut: there was no evidence of even minor
impairment when either drugwas given separately, whereas there
was no sign of discrimination when both were given together
(using the same doses as when they were given separately). Tak-
ing the in vivo and in vitro results together, it follows that block-
ade of the induction of neither LTP/depotentiation nor LTD on
its own prevents the formation of long-term recognition mem-
ory. Either anNR2A- or anNR2B-dependent process is sufficient
to support recognitionmemory; both have to be blocked (as with
AP-5 or both NVP AAM077 and Ro 25-6981 delivered together)
to cause impairment. Therefore, if there is a single memory
mechanism underlying long-term (24 h) perirhinal recognition
memory, it can use compensatory components from either of
two processes (as found in LTP/depotentiation or LTD). Such
compensatory mechanisms might involve different means of
raising intracellular calcium concentrations or convergence
within other intracellular signaling mechanisms. Alternatively,
there must be two independent mechanisms underlying such
long-term recognitionmemory, one dependent on a process used
in LTP/depotentiation and another dependent on a process used
in LTD, either being capable of supporting familiarity discrimi-
nation at long delays. If this second alternative is correct, then
there are components of at least three plastic mechanisms under-
lying perirhinal recognitionmemory: one that is kainate receptor
dependent, supporting memory at short delays, and two that are
NMDA receptor dependent, supporting memory at long delays.
This conclusion indicates that memories may potentially be sup-
ported by more than one plastic mechanism. If the complexity of
the situation in the perirhinal cortex is mirrored elsewhere, extra
care will be needed for firm links to be established between arti-
ficially induced plastic processes such as LTP and mechanisms
underlying learning. In particular, especially where results seem
negative, consideration will need to be given to the potential
Figure 3. Perirhinal infusion of AP-5 impairs longer-term (24 h) but not shorter-term (20
min) recognition memory. At both 20 min and 24 h, rats infused with vehicle showed signifi-
cantly greater mean relative exploration of a novel than a familiar object (DR 0: t(6) 4.5,
p 0.01 and t(6) 3.6, p 0.05, respectively). In contrast, for rats infused with AP-5, the
difference in explorationwas significant at 20min but not at 24 h (DR 0: t(6) 4.8, p 0.01
and t(6)0.3,p0.1, respectively). *p0.05, differencebetweenvehicle- andAP-5-treated
groups at the 24 h delay; **p 0.01, difference between the 20 min and 24 h delay in the
AP-5-treated group.
Figure 4. Perirhinal infusion of neither Ro 25-6981, which antagonizes NMDA receptors
containing NR2B subunits, nor NVP AAM077, which antagonizes NMDA receptors containing
NR2A subunits, impaired longer-term (24 h) recognition memory. Both vehicle controls and
both drug groups significantly discriminated between novel and familiar objects (DR 0: Ro
25-6981: t(7) 3.0, p 0.05; controls: t(7) 4.0, p 0.01; NVP AAM077: t(7) 6.4, p
0.001; controls: t(7)6.1,p0.001). Therewasno significant difference between thegroups.
In contrast, perirhinal infusion of Ro 25-6981 (Ro) together with NVP AAM077 (NVP) impaired
longer-term (24 h) recognition memory. The vehicle group showed significantly greater mean
relative exploration of a novel than a familiar object (DR 0: t(7) 3.2, p 0.05),whereas for
the drug group, the difference in exploration was not significant (t(7) 0.7, p 0.1). *p
0.05, difference between the Ro 25-6981- and the combinedNVPAAM077/Ro 25-6981-treated
groups; **p 0.01, difference between the vehicle- and combinedNVPAAM077/Ro 25-6981-
treated groups and between the NVP AAM077- and the combined NVP AAM077/Ro 25–6981-
treated groups.
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involvement of multiple, possibly compensatory, plastic pro-
cesses underlying learning.
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